BPC-157 and TB-500 are not TGA-approved therapeutic agents for general use in Australia.
This can be a problem for your organs, which are now not getting enough oxygen, leading to a whole host of concerning symptoms, which include: Anemia Fatigue and weakness Depression Irritability Yellowing skin Soreness of mouth and tongue Weight loss or decreased appetite Numbness of extremities Vision problems Other neurological and psychological symptoms may include fogginess, confusion, and a shift in personality and behavior
This formulation meets laboratory solvent standards used in controlled research environments
Whatever youre paying them they deserve a raise, seriously
Bislang sind klinische Studien am Menschen begrenzt, obwohl mehrere laufend oder in Planung sind
Such findings suggest a direct correlation between the reduction in adiposity and the augmented expression of 3-AR